Patricia L Watkins1, John M Dagle1, Edward F Bell1, Tarah T Colaizy2. 1. Division of Neonatology, Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA. 2. Division of Neonatology, Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA. Electronic address: Tarah-Colaizy@uiowa.edu.
Abstract
OBJECTIVE: To assess the outcomes in actively managed extremely preterm infants after admission to a neonatal intensive care unit. STUDY DESIGN: Retrospective cohort of 255 infants born at 22-25 weeks of gestation between 2006 and 2015 at a single study institution. Infants were excluded for congenital anomaly, death in delivery room, or parental request for palliation (n = 7). Neurodevelopmental outcomes were analyzed for 169 of 214 survivors (78.9%) at 18-22 months of corrected age. Outcomes were evaluated using the Mann-Whitney U, χ2, or Fisher exact test, where appropriate. In addition, cognitive scores of the Bayley Scales of Infant-Toddler Development (3rd edition) were assessed using generalized estimating equations. RESULTS: Seventy infants born at 22-23 weeks of gestation (22 weeks, n = 20; 23 weeks, n = 50) and 178 infants born at 24-25 weeks of gestation (24 weeks, n = 79; 25 weeks, n = 99 infants) were included. Survival to hospital discharge of those surviving to NICU admission was 78% (55/70; 95% CI, 69%-88%) at 22-23 weeks and 89% (159/178; 95% CI, 84%-93% at 24-25 weeks; P = .02). No or mild neurodevelopmental impairment in surviving infants was 64% (29/45; 95% CI, 50%-77%) at 22-23 weeks and 76% (94/124; 95% CI, 68%-83%; P = .16) at 24-25 weeks. CONCLUSIONS: Although survival was lower in infants born at 22-23 weeks than at 24-25 weeks of gestation, the majority of survivors in both groups had positive outcomes with no or mild neurodevelopmental impairments. Further evaluation of school performance is warranted.
OBJECTIVE: To assess the outcomes in actively managed extremely preterm infants after admission to a neonatal intensive care unit. STUDY DESIGN: Retrospective cohort of 255 infants born at 22-25 weeks of gestation between 2006 and 2015 at a single study institution. Infants were excluded for congenital anomaly, death in delivery room, or parental request for palliation (n = 7). Neurodevelopmental outcomes were analyzed for 169 of 214 survivors (78.9%) at 18-22 months of corrected age. Outcomes were evaluated using the Mann-Whitney U, χ2, or Fisher exact test, where appropriate. In addition, cognitive scores of the Bayley Scales of Infant-Toddler Development (3rd edition) were assessed using generalized estimating equations. RESULTS: Seventy infants born at 22-23 weeks of gestation (22 weeks, n = 20; 23 weeks, n = 50) and 178 infants born at 24-25 weeks of gestation (24 weeks, n = 79; 25 weeks, n = 99 infants) were included. Survival to hospital discharge of those surviving to NICU admission was 78% (55/70; 95% CI, 69%-88%) at 22-23 weeks and 89% (159/178; 95% CI, 84%-93% at 24-25 weeks; P = .02). No or mild neurodevelopmental impairment in surviving infants was 64% (29/45; 95% CI, 50%-77%) at 22-23 weeks and 76% (94/124; 95% CI, 68%-83%; P = .16) at 24-25 weeks. CONCLUSIONS: Although survival was lower in infants born at 22-23 weeks than at 24-25 weeks of gestation, the majority of survivors in both groups had positive outcomes with no or mild neurodevelopmental impairments. Further evaluation of school performance is warranted.
Authors: Xuxin Chen; Tianyao Lu; Jeffrey Gould; Susan R Hintz; Deirdre J Lyell; Xiao Xu; Lillian Sie; Matthew Rysavy; Alexis S Davis; Henry C Lee Journal: J Pediatr Date: 2022-06-15 Impact factor: 6.314
Authors: Shin Ae Yoon; Yun Sil Chang; Misun Yang; So Yoon Ahn; Se In Sung; Hee-Seung Cho; Won Soon Park Journal: Sci Rep Date: 2022-06-11 Impact factor: 4.996
Authors: Matthew A Rysavy; Katrin Mehler; André Oberthür; Johan Ågren; Satoshi Kusuda; Patrick J McNamara; Regan E Giesinger; Angela Kribs; Erik Normann; Susan J Carlson; Jonathan M Klein; Carl H Backes; Edward F Bell Journal: J Pediatr Date: 2021-03-07 Impact factor: 6.314
Authors: Laura Chavez; Julia Meguro; Shaoyi Chen; Vanessa Nunes de Paiva; Ronald Zambrano; Julia M Eterno; Rahul Kumar; Matthew R Duncan; Merline Benny; Karen C Young; W Dalton Dietrich; Roberta Brambilla; Shu Wu; Augusto F Schmidt Journal: J Neuroinflammation Date: 2021-12-29 Impact factor: 8.322
Authors: Khyzer B Aziz; Orlyn C Lavilla; James L Wynn; Allison C Lure; Daniel Gipson; Diomel de la Cruz Journal: J Perinatol Date: 2021-03-12 Impact factor: 2.521